[Creative France] Biotech in France [fr]
Key info in 10 points about biotech in France.
1. FRANCE HAS 23 LISTED BIOTECH COMPANIES
France is the world’s fourth largest biotech industry, after the United Kingdom, Israel and Sweden, with revenues of US$3.9 billion (up 13% from 2012). (Beyond Borders, Biotechnology Industry, EY 2014)
2. INSERM IS EUROPE’S LEADING ACADEMIC BIOTECH RESEARCH INSTITUTE
Inserm is France and Europe’s leading academic body for filing biotech patents at the European Patent Office. (Facts & Figures 2014, France Biotech)
3. ACADEMIC RESEARCH DRIVING BIOTECH IN FRANCE
54 % of biotech firms founded in France are spin-offs from academic research. (France’s Life Sciences Industry Panorama 2013, France Biotech)
4. SEVEN PHARMA/BIOTECH INNOVATION CLUSTERS
Seven innovation clusters: Lyon Biopôle (world-class cluster, Rhône-Alpes), Medicen (world-class cluster, Paris region), Alsace Biovalley (world-class candidate cluster, Alsace), Atlantic Biotherapies (Pays de la Loire), Cancer Bio Santé (Midi-Pyrénées, Limousin), Eurobiomed (Languedoc Roussillon, Provence-Alpes-Côte d’Azur) and Nutrition Santé Longévité (Nord-Pas de Calais).
5. PARIS: EUROPE’S LEADING STOCK EXCHANGE FOR THE BIOMEDTECH SECTOR
Nine French firms in the sector, valued at €237 million, were floated in 2014, making Paris the leading stock exchange for the sector in Europe. (Facts & Figures 2014, France Biotech)
6. PARTNERSHIPS IN RESEARCH AND INDUSTRY
A variety of complementary partnerships exist in France: 45% are partnerships with academic research, 26% with manufacturers and 17% with the biotech sector.
7. FRANCE IS A BIOTECH PIONEER
Since Cayla was founded in 1977, the sector has grown to become 250 companies strong in 2013, a third of which are more than 10 years old. (France’s Life Sciences Industry Panorama 2013, France Biotech)
8. FOREIGN BIOTECH INVESTMENT IN FRANCE
Twenty-six foreign investment projects were recorded in 2014 in France’s biotech sector, including investments by: the laboratory division of German pharmaceutical firm Merck KGaA in its innovation center in the Alsace region; the French subsidiary 4P Pharma of Israeli firm Pharmaseed, which set up an R&D center at the Institut Pasteur in Lille as part of the EuraSanté incubator. (Business France, 2015)
9. ONGOING GOVERNMENT SUPPORT
France’s research tax credit (since 1983), National Research Agency founded in 2005, InnoBio investment funds created in 2009.
10. GOVERNMENT COMMITMENT TO BIOTECH DEVELOPMENT
“Medicine of the Future” initiative: digital solutions, medical biotechnologies, and medical devices. This governmental strategy aims to modernize the French medical industry through new digital technologies.
- Biotech in France (press kit, PDF, 267,7 Ko)
- (PDF - 267.7 kb)